Early Access — free while we kick the tires
EdgarHawk

Wasman Jane

Director

Director
1 filing analyzed · 1 company · Latest 2025-06-02

Companies

Company Buys Sells Direction
SELLAS Life Sciences Group, Inc. SLS 1 0 Net buying

Activity

June 2025
Buy
20,000 shares
$33,800
Significance 6/10

Director Jane Wasman buys 20,000 SLS shares at $1.69; nearly triples holdings to 30,400 shares amid -100.0% revenue collapse.

Director Jane Wasman purchased 20,000 shares at $1.69 on 2025-05-30, increasing her holdings by 192.3% from 10,400 to 30,400 shares. The transaction occurs in a company with severe operational stress: latest quarterly revenue is $0.00, full-year net income was $-5,813,000.00, and annual revenue growth stands at -100.0%. The stock currently trades at $1.58, down 18.6% from its 52-week high of $1.94, placing the purchase price above the current level. This acquisition by a director during a period of zero revenue and substantial losses warrants investor scrutiny regarding both the operational challenges facing SELLAS and the director's confidence thesis in a turnaround.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access